The Open Pharmacoeconomics & Health Economics Journal - Volume 4 (2012)
The Open Pharmacoeconomics & Health Economics Journal, Volume: 4 (2012) : 1-7 [Electronic Publication Date: February 3, 2012]
DOI: 10.2174/1876824501204010001
DOI: 10.2174/1876824501204010001
- Author: Pedro Plans-Rubio
The Open Pharmacoeconomics & Health Economics Journal, Volume: 4 (2012) : 8-17 [Electronic Publication Date: March 22, 2012]
DOI: 10.2174/1876824501204010008
DOI: 10.2174/1876824501204010008
- Authors: Robert Hettle , Koo Wilson , Tunde Peter , Juris Ezernieks , Dieter Hackl and Christopher Wolf
Economic Analysis of Alemtuzumab (MabCampath®) in Fludarabinerefractory
Chronic Lymphocytic Leukemia
The Open Pharmacoeconomics & Health Economics Journal, Volume: 4 (2012) : 18-25 [Electronic Publication Date: April 6, 2012]
DOI: 10.2174/1876824501204010018
DOI: 10.2174/1876824501204010018
- Authors: N. Mittmann , P. K. Isogai , J. M. Connors , M. Rebeira and M. C. Cheung
The Open Pharmacoeconomics & Health Economics Journal, Volume: 4 (2012) : 26-35 [Electronic Publication Date: April 13, 2012]
DOI: 10.2174/1876824501204010026
DOI: 10.2174/1876824501204010026
- Authors: Paolo Cremonesi , Marcello Montefiori and Marina Resta